New antiviral research on Brilacidin in vitro antiviral activity in bunyaviruses and alphaviruses has been accepted for a Poster Presentation at the 2022 Military Health System Research Symposium (MHSRS), taking place September 12-15, 2022, at the Gaylord Palms Resort and Convention Center, Kissimmee, FL.

The MHSRS is an annual four-day scientific symposium sponsored by the U.S. Department of Defense.

The poster -- Brilacidin, a Host Defense Peptide Mimetic, is a Broad-Spectrum Countermeasure Strategy Against Acutely Infectious Viruses -- will be part of the Development of New Front Line Therapies to Prevent and Treat Endemic Viral Diseases (non-SARS-CoV-2) Breakout Session.

The poster in now available for download by clicking here.